3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
3
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms
2
Small Cell Lung Carcinoma
1
Sleep Wake Disorders
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Obesity
1
Multiple Myeloma
1
Melanoma
1
Malignant Solid Neoplasm
1
Malignant Primary Pelvic Neoplasm
1
Lymphoma, Non-Hodgkin
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Inflammatory Breast Neoplasms
1
Hodgkin Disease
1
Hematopoietic and Lymphatic System Neoplasm
1
Hematologic Neoplasms
1
Heart Defects, Congenital
1
Fatigue
1
Depression
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Clinical Stage I Esophageal Adenocarcinoma American Joint Committee on Cancer (AJCC) v8
1
Carcinoma, Merkel Cell
1
Anxiety Disorders
1
Anatomic Stage I Breast Cancer AJCC v8
1
Interventions
Echocardiography
2
empagliflozin
1
Social Determinants of Health
1
Hematologic Tests
1
Environmental Biomarkers
1
Carvedilol
1
Cardiography, Impedance
1
Blood Pressure Determination
1
(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Cardiotoxicity
×
Exercise Test
×
90 days
×
Clear all
No trials found.